ArticleWorld journal of stem cells2026
Synergistic potential of combined neural stem cells and mesenchymal stem cells therapy in acute cerebral infarction: A perspective.
Article in World journal of stem cells, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute cerebral infarction (ACI) is one of the leading causes of mortality and long-term disability in adults, often resulting in neuronal loss and necrosis, accompanied by severe neurological deficits. Neural stem cells and mesenchymal stem cells play crucial roles in neural repair and protection, primarily through promoting angiogenesis, reconstructing neural networks, and inhibiting neuronal apoptosis. A recent randomized controlled trial demonstrated that combined neural stem cell and mesenchymal stem cell therapy significantly enhances neurological recovery in ACI patients by upregulating the expression of vascular endothelial growth factor and basic fibroblast growth factor. This study provides a theoretical foundation and clinical support for the application of stem cell-based precision medicine in ACI. This letter shares our perspectives on the combined stem cell therapy for ACI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.